- Home
- CTMX vs FNGR Comparison
CTMX vs FNGR Comparison
Compare CTMX & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- FNGR
- Stock Information
- Founded
- CTMX 2008
- FNGR 2016
- Country
- CTMX United States
- FNGR Singapore
- Employees
- CTMX N/A
- FNGR N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- FNGR Computer Software: Prepackaged Software
- Sector
- CTMX Health Care
- FNGR Technology
- Exchange
- CTMX Nasdaq
- FNGR Nasdaq
- Market Cap
- CTMX 85.3M
- FNGR 68.3M
- IPO Year
- CTMX 2015
- FNGR N/A
- Fundamental
- Price
- CTMX $0.84
- FNGR $1.18
- Analyst Decision
- CTMX Buy
- FNGR
- Analyst Count
- CTMX 6
- FNGR 0
- Target Price
- CTMX $5.77
- FNGR N/A
- AVG Volume (30 Days)
- CTMX 1.2M
- FNGR 535.3K
- Earning Date
- CTMX 03-10-2025
- FNGR 01-14-2025
- Dividend Yield
- CTMX N/A
- FNGR N/A
- EPS Growth
- CTMX N/A
- FNGR N/A
- EPS
- CTMX 0.16
- FNGR N/A
- Revenue
- CTMX $126,617,000.00
- FNGR $33,570,107.00
- Revenue This Year
- CTMX $22.55
- FNGR $260.03
- Revenue Next Year
- CTMX N/A
- FNGR N/A
- P/E Ratio
- CTMX $5.20
- FNGR N/A
- Revenue Growth
- CTMX 33.66
- FNGR N/A
- 52 Week Low
- CTMX $0.79
- FNGR $1.03
- 52 Week High
- CTMX $5.85
- FNGR $3.96
- Technical
- Relative Strength Index (RSI)
- CTMX 33.95
- FNGR 35.93
- Support Level
- CTMX $0.79
- FNGR $1.10
- Resistance Level
- CTMX $1.17
- FNGR $1.27
- Average True Range (ATR)
- CTMX 0.08
- FNGR 0.09
- MACD
- CTMX -0.03
- FNGR 0.02
- Stochastic Oscillator
- CTMX 13.16
- FNGR 40.00
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.